TY - JOUR AU - Jullien, M. AU - Gomez-Bougie, P. AU - Chiron, D. AU - Touzeau, C. PY - 2020 DA - 2020// TI - Restoring apoptosis with BH3 mimetics in mature B-cell malignancies JO - Cells. VL - 9 UR - https://doi.org/10.3390/cells9030717 DO - 10.3390/cells9030717 ID - Jullien2020 ER - TY - JOUR AU - Liang, J. AU - Zhao, W. AU - Tong, P. AU - Li, P. AU - Zhao, Y. AU - Li, H. PY - 2020 DA - 2020// TI - Comprehensive molecular characterization of inhibitors of apoptosis proteins (IAPs) for therapeutic targeting in cancer JO - BMC Med Genomics VL - 13 UR - https://doi.org/10.1186/s12920-020-0661-x DO - 10.1186/s12920-020-0661-x ID - Liang2020 ER - TY - JOUR AU - Wang, D. AU - Berglund, A. AU - Kenchappa, R. S. AU - Forsyth, P. A. AU - Mule, J. J. AU - Etame, A. B. PY - 2016 DA - 2016// TI - BIRC3 is a novel driver of therapeutic resistance in Glioblastoma JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep21710 DO - 10.1038/srep21710 ID - Wang2016 ER - TY - JOUR AU - Cossu, F. AU - Milani, M. AU - Mastrangelo, E. AU - Lecis, D. PY - 2019 DA - 2019// TI - Targeting the BIR domains of inhibitor of apoptosis (IAP) Proteins in Cancer Treatment JO - Comput Struct Biotechnol J VL - 17 UR - https://doi.org/10.1016/j.csbj.2019.01.009 DO - 10.1016/j.csbj.2019.01.009 ID - Cossu2019 ER - TY - JOUR AU - Fulda, S. PY - 2015 DA - 2015// TI - Promises and challenges of smac mimetics as cancer therapeutics JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-15-0365 DO - 10.1158/1078-0432.CCR-15-0365 ID - Fulda2015 ER - TY - JOUR AU - Dietz, A. AU - Dalda, N. AU - Zielke, S. AU - Dittmann, J. AU - Wijk, S. J. L. AU - Vogler, M. PY - 2020 DA - 2020// TI - Proteasome inhibitors and Smac mimetics cooperate to induce cell death in diffuse large B-cell lymphoma by stabilizing NOXA and triggering mitochondrial apoptosis JO - Int J Cancer. UR - https://doi.org/10.1002/ijc.32976 DO - 10.1002/ijc.32976 ID - Dietz2020 ER - TY - JOUR AU - Bhosale, P. G. AU - Cristea, S. AU - Ambatipudi, S. AU - Desai, R. S. AU - Kumar, R. AU - Patil, A. PY - 2017 DA - 2017// TI - Chromosomal alterations and gene expression changes associated with the progression of leukoplakia to advanced gingivobuccal cancer JO - Transl Oncol VL - 10 UR - https://doi.org/10.1016/j.tranon.2017.03.008 DO - 10.1016/j.tranon.2017.03.008 ID - Bhosale2017 ER - TY - JOUR AU - Bhosale, P. G. AU - Pandey, M. AU - Cristea, S. AU - Shah, M. AU - Patil, A. AU - Beerenwinkel, N. PY - 2017 DA - 2017// TI - Recurring Amplification at 11q22.1-q22.2 locus plays an important role in lymph node metastasis and radioresistance in OSCC JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/s41598-017-16247-y DO - 10.1038/s41598-017-16247-y ID - Bhosale2017 ER - TY - JOUR AU - Tessoulin, B. AU - Papin, A. AU - Gomez-Bougie, P. AU - Bellanger, C. AU - Amiot, M. AU - Pellat-Deceunynck, C. PY - 2018 DA - 2018// TI - BCL2-family dysregulation in B-cell malignancies: from gene expression regulation to a targeted therapy biomarker JO - Front Oncol VL - 8 UR - https://doi.org/10.3389/fonc.2018.00645 DO - 10.3389/fonc.2018.00645 ID - Tessoulin2018 ER - TY - JOUR AU - Mohammad, R. M. AU - Muqbil, I. AU - Lowe, L. AU - Yedjou, C. AU - Hsu, H. Y. AU - Lin, L. T. PY - 2015 DA - 2015// TI - Broad targeting of resistance to apoptosis in cancer JO - Semin Cancer Biol VL - 35 UR - https://doi.org/10.1016/j.semcancer.2015.03.001 DO - 10.1016/j.semcancer.2015.03.001 ID - Mohammad2015 ER - TY - JOUR AU - Perini, G. F. AU - Ribeiro, G. N. AU - Pinto Neto, J. V. AU - Campos, L. T. AU - Hamerschlak, N. PY - 2018 DA - 2018// TI - BCL-2 as therapeutic target for hematological malignancies JO - J Hematol Oncol VL - 11 UR - https://doi.org/10.1186/s13045-018-0608-2 DO - 10.1186/s13045-018-0608-2 ID - Perini2018 ER - TY - JOUR AU - Mohamed, M. S. AU - Bishr, M. K. AU - Almutairi, F. M. AU - Ali, A. G. PY - 2017 DA - 2017// TI - Inhibitors of apoptosis: clinical implications in cancer JO - Apoptosis VL - 22 UR - https://doi.org/10.1007/s10495-017-1429-4 DO - 10.1007/s10495-017-1429-4 ID - Mohamed2017 ER - TY - JOUR AU - Crook, N. E. AU - Clem, R. J. AU - Miller, L. K. PY - 1993 DA - 1993// TI - An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif JO - J Virol VL - 67 UR - https://doi.org/10.1128/JVI.67.4.2168-2174.1993 DO - 10.1128/JVI.67.4.2168-2174.1993 ID - Crook1993 ER - TY - JOUR AU - Eckelman, B. P. AU - Drag, M. AU - Snipas, S. J. AU - Salvesen, G. S. PY - 2008 DA - 2008// TI - The mechanism of peptide-binding specificity of IAP BIR domains JO - Cell Death Differ VL - 15 UR - https://doi.org/10.1038/cdd.2008.6 DO - 10.1038/cdd.2008.6 ID - Eckelman2008 ER - TY - JOUR AU - Yang, H. AU - Han, M. AU - Li, H. PY - 2020 DA - 2020// TI - Construction and validation of an autophagy-related prognostic risk signature for survival predicting in clear cell renal cell carcinoma patients JO - Front Oncol VL - 10 UR - https://doi.org/10.3389/fonc.2020.00707 DO - 10.3389/fonc.2020.00707 ID - Yang2020 ER - TY - JOUR AU - Devis-Jauregui, L. AU - Eritja, N. AU - Davis, M. L. AU - Matias-Guiu, X. AU - Llobet-Navas, D. PY - 2020 DA - 2020// TI - Autophagy in the physiological endometrium and cancer JO - Autophagy. UR - https://doi.org/10.1080/15548627.2020.1752548 DO - 10.1080/15548627.2020.1752548 ID - Devis-Jauregui2020 ER - TY - JOUR AU - Liu, D. AU - Yang, Y. AU - Liu, Q. AU - Wang, J. PY - 2011 DA - 2011// TI - Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells JO - Med Oncol VL - 28 UR - https://doi.org/10.1007/s12032-009-9397-3 DO - 10.1007/s12032-009-9397-3 ID - Liu2011 ER - TY - JOUR AU - Xi, G. AU - Hu, X. AU - Wu, B. AU - Jiang, H. AU - Young, C. Y. AU - Pang, Y. PY - 2011 DA - 2011// TI - Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells JO - Cancer Lett VL - 307 UR - https://doi.org/10.1016/j.canlet.2011.03.026 DO - 10.1016/j.canlet.2011.03.026 ID - Xi2011 ER - TY - JOUR AU - Dupere-Richer, D. AU - Kinal, M. AU - Menasche, V. AU - Nielsen, T. H. AU - Rincon, S. AU - Pettersson, F. PY - 2013 DA - 2013// TI - Vorinostat-induced autophagy switches from a death-promoting to a cytoprotective signal to drive acquired resistance JO - Cell Death Dis VL - 4 UR - https://doi.org/10.1038/cddis.2012.210 DO - 10.1038/cddis.2012.210 ID - Dupere-Richer2013 ER - TY - JOUR AU - Yamamoto, K. AU - Venida, A. AU - Yano, J. AU - Biancur, D. E. AU - Kakiuchi, M. AU - Gupta, S. PY - 2020 DA - 2020// TI - Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I JO - Nature VL - 581 UR - https://doi.org/10.1038/s41586-020-2229-5 DO - 10.1038/s41586-020-2229-5 ID - Yamamoto2020 ER - TY - JOUR AU - Wang, S. Y. AU - Yu, Q. J. AU - Zhang, R. D. AU - Liu, B. PY - 2011 DA - 2011// TI - Core signaling pathways of survival/death in autophagy-related cancer networks JO - Int J Biochem Cell Biol VL - 43 UR - https://doi.org/10.1016/j.biocel.2011.05.010 DO - 10.1016/j.biocel.2011.05.010 ID - Wang2011 ER - TY - JOUR AU - Shimamura, T. AU - Lowell, A. M. AU - Engelman, J. A. AU - Shapiro, G. I. PY - 2005 DA - 2005// TI - Epidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-05-0933 DO - 10.1158/0008-5472.CAN-05-0933 ID - Shimamura2005 ER - TY - JOUR AU - Shimamura, T. AU - Li, D. AU - Ji, H. AU - Haringsma, H. J. AU - Liniker, E. AU - Borgman, C. L. PY - 2008 DA - 2008// TI - Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-5428 DO - 10.1158/0008-5472.CAN-07-5428 ID - Shimamura2008 ER - TY - JOUR AU - Shimamura, T. AU - Perera, S. A. AU - Foley, K. P. AU - Sang, J. AU - Rodig, S. J. AU - Inoue, T. PY - 2012 DA - 2012// TI - Ganetespib (STA-9090), a nongeldanamycin HSP90 inhibitor, has potent antitumor activity in in vitro and in vivo models of non-small cell lung cancer JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-2967 DO - 10.1158/1078-0432.CCR-11-2967 ID - Shimamura2012 ER - TY - JOUR AU - Bizarro, A. AU - Sousa, D. AU - Lima, R. T. AU - Musso, L. AU - Cincinelli, R. AU - Zuco, V. PY - 2018 DA - 2018// TI - Synthesis and evaluation of the tumor cell growth inhibitory potential of new putative HSP90 inhibitors JO - Molecules. VL - 23 UR - https://doi.org/10.3390/molecules23020407 DO - 10.3390/molecules23020407 ID - Bizarro2018 ER - TY - JOUR AU - Liu, J. AU - Sun, W. AU - Dong, W. AU - Wang, Z. AU - Qin, Y. AU - Zhang, T. PY - 2017 DA - 2017// TI - HSP90 inhibitor NVP-AUY922 induces cell apoptosis by disruption of the survivin in papillary thyroid carcinoma cells JO - Biochem Biophys Res Commun VL - 487 UR - https://doi.org/10.1016/j.bbrc.2017.04.056 DO - 10.1016/j.bbrc.2017.04.056 ID - Liu2017 ER - TY - JOUR AU - Watt, P. J. AU - Maske, C. P. AU - Hendricks, D. T. AU - Parker, M. I. AU - Denny, L. AU - Govender, D. PY - 2009 DA - 2009// TI - The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation JO - Int J Cancer VL - 124 UR - https://doi.org/10.1002/ijc.24146 DO - 10.1002/ijc.24146 ID - Watt2009 ER - TY - JOUR AU - Ben-Barouch, S. AU - Kuruvilla, J. PY - 2020 DA - 2020// TI - Selinexor (KTP-330) - a selective inhibitor of nuclear export (SINE): anti-tumor activity in diffuse large B-cell lymphoma (DLBCL) JO - Expert Opin Investig Drugs VL - 29 UR - https://doi.org/10.1080/13543784.2020.1706087 DO - 10.1080/13543784.2020.1706087 ID - Ben-Barouch2020 ER - TY - JOUR AU - Fischer, M. A. AU - Friedlander, S. Y. AU - Arrate, M. P. AU - Chang, H. AU - Gorska, A. E. AU - Fuller, L. D. PY - 2020 DA - 2020// TI - Venetoclax response is enhanced by selective inhibitor of nuclear export compounds in hematologic malignancies JO - Blood Adv VL - 4 UR - https://doi.org/10.1182/bloodadvances.2019000359 DO - 10.1182/bloodadvances.2019000359 ID - Fischer2020 ER - TY - JOUR AU - Frazzi, R. AU - Auffray, C. AU - Ferrari, A. AU - Filippini, P. AU - Rutella, S. AU - Cesario, A. PY - 2016 DA - 2016// TI - Integrative systems medicine approaches to identify molecular targets in lymphoid malignancies JO - J Transl Med VL - 14 UR - https://doi.org/10.1186/s12967-016-1018-2 DO - 10.1186/s12967-016-1018-2 ID - Frazzi2016 ER - TY - JOUR AU - Li, Y. W. Y. AU - Wang, Z. AU - Yi, D. AU - Ma, S. PY - 2015 DA - 2015// TI - Racial differences in three major NHL subtypes: descriptive epidemiology JO - Cancer Epidemiol VL - 39 UR - https://doi.org/10.1016/j.canep.2014.12.001 DO - 10.1016/j.canep.2014.12.001 ID - Li2015 ER - TY - JOUR AU - Berndt, S. I. AU - Camp, N. J. AU - Skibola, C. F. AU - Vijai, J. AU - Wang, Z. AU - Gu, J. PY - 2016 DA - 2016// TI - Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia JO - Nat Commun VL - 7 UR - https://doi.org/10.1038/ncomms10933 DO - 10.1038/ncomms10933 ID - Berndt2016 ER - TY - JOUR AU - Dohner, H. AU - Stilgenbauer, S. AU - Benner, A. AU - Leupolt, E. AU - Krober, A. AU - Bullinger, L. PY - 2000 DA - 2000// TI - Genomic aberrations and survival in chronic lymphocytic leukemia JO - N Engl J Med VL - 343 UR - https://doi.org/10.1056/NEJM200012283432602 DO - 10.1056/NEJM200012283432602 ID - Dohner2000 ER - TY - JOUR AU - Krober, A. AU - Bloehdorn, J. AU - Hafner, S. AU - Buhler, A. AU - Seiler, T. AU - Kienle, D. PY - 2006 DA - 2006// TI - Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.03.7184 DO - 10.1200/JCO.2005.03.7184 ID - Krober2006 ER - TY - JOUR AU - Puiggros, A. AU - Blanco, G. AU - Espinet, B. PY - 2014 DA - 2014// TI - Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we go JO - Biomed Res Int VL - 2014 UR - https://doi.org/10.1155/2014/435983 DO - 10.1155/2014/435983 ID - Puiggros2014 ER - TY - JOUR AU - Nabhan, C. AU - Raca, G. AU - Wang, Y. L. PY - 2015 DA - 2015// TI - Predicting prognosis in chronic lymphocytic leukemia in the contemporary era JO - JAMA Oncol VL - 1 UR - https://doi.org/10.1001/jamaoncol.2015.0779 DO - 10.1001/jamaoncol.2015.0779 ID - Nabhan2015 ER - TY - JOUR AU - Rose-Zerilli, M. J. AU - Forster, J. AU - Parker, H. AU - Parker, A. AU - Rodriguez, A. E. AU - Chaplin, T. PY - 2014 DA - 2014// TI - ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial JO - Haematologica VL - 99 UR - https://doi.org/10.3324/haematol.2013.098574 DO - 10.3324/haematol.2013.098574 ID - Rose-Zerilli2014 ER - TY - JOUR AU - Rossi, D. AU - Fangazio, M. AU - Rasi, S. AU - Vaisitti, T. AU - Monti, S. AU - Cresta, S. PY - 2012 DA - 2012// TI - Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia JO - Blood VL - 119 UR - https://doi.org/10.1182/blood-2011-12-395673 DO - 10.1182/blood-2011-12-395673 ID - Rossi2012 ER - TY - JOUR AU - Chiaretti, S. AU - Marinelli, M. AU - Del Giudice, I. AU - Bonina, S. AU - Piciocchi, A. AU - Messina, M. PY - 2014 DA - 2014// TI - NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment JO - Leuk Lymphoma VL - 55 UR - https://doi.org/10.3109/10428194.2014.898760 DO - 10.3109/10428194.2014.898760 ID - Chiaretti2014 ER - TY - JOUR AU - Rossi, D. AU - Rasi, S. AU - Spina, V. AU - Bruscaggin, A. AU - Monti, S. AU - Ciardullo, C. PY - 2013 DA - 2013// TI - Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-09-458265 DO - 10.1182/blood-2012-09-458265 ID - Rossi2013 ER - TY - JOUR AU - Tausch, E. AU - Stilgenbauer, S. PY - 2020 DA - 2020// TI - BIRC3 mutations in chronic lymphocytic leukemia—uncommon and unfavorable JO - Haematologica VL - 105 UR - https://doi.org/10.3324/haematol.2019.238691 DO - 10.3324/haematol.2019.238691 ID - Tausch2020 ER - TY - JOUR AU - Raponi, S. AU - Del Giudice, I. AU - Ilari, C. AU - Cafforio, L. AU - Messina, M. AU - Cappelli, L. V. PY - 2019 DA - 2019// TI - Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease JO - Br J Haematol VL - 185 UR - https://doi.org/10.1111/bjh.15405 DO - 10.1111/bjh.15405 ID - Raponi2019 ER - TY - JOUR AU - Diop, F. AU - Moia, R. AU - Favini, C. AU - Spaccarotella, E. AU - Paoli, L. AU - Bruscaggin, A. PY - 2020 DA - 2020// TI - Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia JO - Haematologica VL - 105 UR - https://doi.org/10.3324/haematol.2019.219550 DO - 10.3324/haematol.2019.219550 ID - Diop2020 ER - TY - JOUR AU - Blakemore, S. J. AU - Clifford, R. AU - Parker, H. AU - Antoniou, P. AU - Stec-Dziedzic, E. AU - Larrayoz, M. PY - 2020 DA - 2020// TI - Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial JO - Leukemia. VL - 34 UR - https://doi.org/10.1038/s41375-020-0723-2 DO - 10.1038/s41375-020-0723-2 ID - Blakemore2020 ER - TY - JOUR AU - Rossi, D. AU - Deaglio, S. AU - Dominguez-Sola, D. AU - Rasi, S. AU - Vaisitti, T. AU - Agostinelli, C. PY - 2011 DA - 2011// TI - Alteration of BIRC3 and multiple other NF-kappaB pathway genes in splenic marginal zone lymphoma JO - Blood VL - 118 UR - https://doi.org/10.1182/blood-2011-06-359166 DO - 10.1182/blood-2011-06-359166 ID - Rossi2011 ER - TY - JOUR AU - Darding, M. AU - Feltham, R. AU - Tenev, T. AU - Bianchi, K. AU - Benetatos, C. AU - Silke, J. PY - 2011 DA - 2011// TI - Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2 JO - Cell Death Differ VL - 18 UR - https://doi.org/10.1038/cdd.2011.10 DO - 10.1038/cdd.2011.10 ID - Darding2011 ER - TY - JOUR AU - Feltham, R. AU - Bettjeman, B. AU - Budhidarmo, R. AU - Mace, P. D. AU - Shirley, S. AU - Condon, S. M. PY - 2011 DA - 2011// TI - Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization JO - J Biol Chem VL - 286 UR - https://doi.org/10.1074/jbc.M111.222919 DO - 10.1074/jbc.M111.222919 ID - Feltham2011 ER - TY - JOUR AU - Yang, Q. H. AU - Du, C. PY - 2004 DA - 2004// TI - Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells JO - J Biol Chem VL - 279 UR - https://doi.org/10.1074/jbc.M401253200 DO - 10.1074/jbc.M401253200 ID - Yang2004 ER - TY - JOUR AU - Albano, F. AU - Chiurazzi, F. AU - Mimmi, S. AU - Vecchio, E. AU - Pastore, A. AU - Cimmino, C. PY - 2018 DA - 2018// TI - The expression of inhibitor of bruton’s tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis JO - Cell Death Dis VL - 9 UR - https://doi.org/10.1038/s41419-017-0026-3 DO - 10.1038/s41419-017-0026-3 ID - Albano2018 ER - TY - JOUR AU - Balakrishnan, K. AU - Fu, M. AU - Onida, F. AU - Wierda, W. G. AU - Keating, M. J. AU - Gandhi, V. PY - 2016 DA - 2016// TI - Reactivation of Smac-mediated apoptosis in chronic lymphocytic leukemia cells: mechanistic studies of Smac mimetic JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.8462 DO - 10.18632/oncotarget.8462 ID - Balakrishnan2016 ER - TY - JOUR AU - Onaindia, A. AU - Medeiros, L. J. AU - Patel, K. P. PY - 2017 DA - 2017// TI - Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms JO - Mod Pathol VL - 30 UR - https://doi.org/10.1038/modpathol.2017.58 DO - 10.1038/modpathol.2017.58 ID - Onaindia2017 ER - TY - JOUR AU - Hershkovitz-Rokah, O. AU - Pulver, D. AU - Lenz, G. AU - Shpilberg, O. PY - 2018 DA - 2018// TI - Ibrutinib resistance in mantle cell lymphoma: clinical, molecular and treatment aspects JO - Br J Haematol VL - 181 UR - https://doi.org/10.1111/bjh.15108 DO - 10.1111/bjh.15108 ID - Hershkovitz-Rokah2018 ER - TY - JOUR AU - Rahal, R. AU - Frick, M. AU - Romero, R. AU - Korn, J. M. AU - Kridel, R. AU - Chan, F. C. PY - 2014 DA - 2014// TI - Pharmacological and genomic profiling identifies NF-kappaB-targeted treatment strategies for mantle cell lymphoma JO - Nat Med VL - 20 UR - https://doi.org/10.1038/nm.3435 DO - 10.1038/nm.3435 ID - Rahal2014 ER - TY - JOUR AU - Jain, P. AU - Wang, M. PY - 2019 DA - 2019// TI - Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management JO - Am J Hematol VL - 94 UR - https://doi.org/10.1002/ajh.25487 DO - 10.1002/ajh.25487 ID - Jain2019 ER - TY - JOUR AU - Dolecek, T. A. AU - Propp, J. M. AU - Stroup, N. E. AU - Kruchko, C. PY - 2012 DA - 2012// TI - CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009 JO - Neuro Oncol VL - 14 UR - https://doi.org/10.1093/neuonc/nos218 DO - 10.1093/neuonc/nos218 ID - Dolecek2012 ER - TY - JOUR AU - Gressot, L. V. AU - Doucette, T. AU - Yang, Y. AU - Fuller, G. N. AU - Manyam, G. AU - Rao, A. PY - 2017 DA - 2017// TI - Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.8657 DO - 10.18632/oncotarget.8657 ID - Gressot2017 ER - TY - JOUR AU - Lu, W. AU - Ning, H. AU - Gu, L. AU - Peng, H. AU - Wang, Q. AU - Hou, R. PY - 2016 DA - 2016// TI - MCPIP1 Selectively Destabilizes Transcripts Associated with an Antiapoptotic Gene Expression Program in Breast Cancer Cells That Can Elicit Complete Tumor Regression JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-15-1115 DO - 10.1158/0008-5472.CAN-15-1115 ID - Lu2016 ER - TY - JOUR AU - Malinovskaya, E. M. AU - Ershova, E. S. AU - Okorokova, N. A. AU - Veiko, V. P. AU - Konkova, M. S. AU - Kozhina, E. A. PY - 2019 DA - 2019// TI - Ribosomal DNA as DAMPs Signal for MCF7 Cancer Cells JO - Front Oncol VL - 9 UR - https://doi.org/10.3389/fonc.2019.00445 DO - 10.3389/fonc.2019.00445 ID - Malinovskaya2019 ER - TY - JOUR AU - Mendoza-Rodriguez, M. AU - Arevalo Romero, H. AU - Fuentes-Panana, E. M. AU - Ayala-Sumuano, J. T. AU - Meza, I. PY - 2017 DA - 2017// TI - IL-1beta induces up-regulation of BIRC3, a gene involved in chemoresistance to doxorubicin in breast cancer cells JO - Cancer Lett VL - 390 UR - https://doi.org/10.1016/j.canlet.2017.01.005 DO - 10.1016/j.canlet.2017.01.005 ID - Mendoza-Rodriguez2017 ER - TY - JOUR AU - Srour, M. K. AU - Gao, B. AU - Dadmanesh, F. AU - Carlson, K. AU - Qu, Y. AU - Deng, N. PY - 2019 DA - 2019// TI - Gene expression comparison between primary triple-negative breast cancer and paired axillary and sentinel lymph node metastasis JO - Breast J VL - 26 UR - https://doi.org/10.1111/tbj.13684 DO - 10.1111/tbj.13684 ID - Srour2019 ER - TY - JOUR AU - Hahm, E. R. AU - Singh, S. V. PY - 2013 DA - 2013// TI - Withaferin A-induced apoptosis in human breast cancer cells is associated with suppression of inhibitor of apoptosis family protein expression JO - Cancer Lett VL - 334 UR - https://doi.org/10.1016/j.canlet.2012.08.026 DO - 10.1016/j.canlet.2012.08.026 ID - Hahm2013 ER - TY - JOUR AU - Flygare, J. A. AU - Beresini, M. AU - Budha, N. AU - Chan, H. AU - Chan, I. T. AU - Cheeti, S. PY - 2012 DA - 2012// TI - Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152) JO - J Med Chem VL - 55 UR - https://doi.org/10.1021/jm300060k DO - 10.1021/jm300060k ID - Flygare2012 ER - TY - JOUR AU - Andersen, M. H. AU - Svane, I. M. AU - Becker, J. C. AU - Straten, P. T. PY - 2007 DA - 2007// TI - The universal character of the tumor-associated antigen survivin JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-07-0686 DO - 10.1158/1078-0432.CCR-07-0686 ID - Andersen2007 ER - TY - JOUR AU - Varughese, R. K. AU - Torp, S. H. PY - 2016 DA - 2016// TI - Survivin and gliomas: a literature review JO - Oncol Lett VL - 12 UR - https://doi.org/10.3892/ol.2016.4867 DO - 10.3892/ol.2016.4867 ID - Varughese2016 ER - TY - JOUR AU - Wheatley, S. P. AU - Altieri, D. C. PY - 2019 DA - 2019// TI - Survivin at a glance JO - J Cell Sci VL - 132 UR - https://doi.org/10.1242/jcs.223826 DO - 10.1242/jcs.223826 ID - Wheatley2019 ER - TY - JOUR AU - Luong-Gardiol, N. AU - Siddiqui, I. AU - Pizzitola, I. AU - Jeevan-Raj, B. AU - Charmoy, M. AU - Huang, Y. PY - 2019 DA - 2019// TI - gamma-Catenin-dependent signals maintain BCR-ABL1(+) B cell acute lymphoblastic leukemia JO - Cancer Cell VL - 35 UR - https://doi.org/10.1016/j.ccell.2019.03.005 DO - 10.1016/j.ccell.2019.03.005 ID - Luong-Gardiol2019 ER - TY - JOUR AU - Runckel, K. AU - Barth, M. J. AU - Mavis, C. AU - Gu, J. J. AU - Hernandez-Ilizaliturri, F. J. PY - 2018 DA - 2018// TI - The SMAC mimetic LCL-161 displays antitumor activity in preclinical models of rituximab-resistant B-cell lymphoma JO - Blood Adv VL - 2 UR - https://doi.org/10.1182/bloodadvances.2018018168 DO - 10.1182/bloodadvances.2018018168 ID - Runckel2018 ER - TY - JOUR AU - Ishikawa, C. AU - Senba, M. AU - Mori, N. PY - 2020 DA - 2020// TI - Evaluation of artesunate for the treatment of adult T-cell leukemia/lymphoma JO - Eur J Pharmacol VL - 872 UR - https://doi.org/10.1016/j.ejphar.2020.172953 DO - 10.1016/j.ejphar.2020.172953 ID - Ishikawa2020 ER - TY - JOUR AU - Kulik, L. AU - El-Serag, H. B. PY - 2019 DA - 2019// TI - Epidemiology and management of hepatocellular carcinoma JO - Gastroenterology VL - 156 UR - https://doi.org/10.1053/j.gastro.2018.08.065 DO - 10.1053/j.gastro.2018.08.065 ID - Kulik2019 ER - TY - JOUR AU - Wang, D. AU - Liu, J. AU - Liu, S. AU - Li, W. PY - 2020 DA - 2020// TI - Identification of crucial genes associated with immune cell infiltration in hepatocellular carcinoma by weighted gene co-expression network analysis JO - Front Genet VL - 11 UR - https://doi.org/10.3389/fgene.2020.00342 DO - 10.3389/fgene.2020.00342 ID - Wang2020 ER - TY - JOUR AU - Fujiya, K. AU - Ohshima, K. AU - Kitagawa, Y. AU - Hatakeyama, K. AU - Nagashima, T. AU - Aizawa, D. PY - 2020 DA - 2020// TI - Aberrant expression of Wnt/beta-catenin signaling pathway genes in aggressive malignant gastric gastrointestinal stromal tumors JO - Eur J Surg Oncol. UR - https://doi.org/10.1016/j.ejso.2020.02.036 DO - 10.1016/j.ejso.2020.02.036 ID - Fujiya2020 ER - TY - JOUR AU - Turner, D. P. AU - Findlay, V. J. AU - Moussa, O. AU - Semenchenko, V. I. AU - Watson, P. M. AU - LaRue, A. C. PY - 2011 DA - 2011// TI - Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression JO - Prostate VL - 71 UR - https://doi.org/10.1002/pros.21389 DO - 10.1002/pros.21389 ID - Turner2011 ER - TY - JOUR AU - Schlomm, T. AU - Iwers, L. AU - Kirstein, P. AU - Jessen, B. AU - Kollermann, J. AU - Minner, S. PY - 2008 DA - 2008// TI - Clinical significance of p53 alterations in surgically treated prostate cancers JO - Mod Pathol VL - 21 UR - https://doi.org/10.1038/modpathol.2008.104 DO - 10.1038/modpathol.2008.104 ID - Schlomm2008 ER - TY - JOUR AU - Hennigs, J. K. AU - Minner, S. AU - Tennstedt, P. AU - Loser, R. AU - Huland, H. AU - Klose, H. PY - 2020 DA - 2020// TI - Subcellular Compartmentalization of survivin is associated with biological aggressiveness and prognosis in prostate cancer JO - Sci Rep VL - 10 UR - https://doi.org/10.1038/s41598-020-60064-9 DO - 10.1038/s41598-020-60064-9 ID - Hennigs2020 ER - TY - JOUR AU - Faccion, R. S. AU - Bernardo, P. S. AU - Lopes, G. P. F. AU - Bastos, L. S. AU - Teixeira, C. L. AU - Oliveira, J. A. PY - 2018 DA - 2018// TI - p53 expression and subcellular survivin localization improve the diagnosis and prognosis of patients with diffuse astrocytic tumors JO - Cell Oncol (Dordr) VL - 41 UR - https://doi.org/10.1007/s13402-017-0361-5 DO - 10.1007/s13402-017-0361-5 ID - Faccion2018 ER - TY - JOUR AU - Conde, M. AU - Michen, S. AU - Wiedemuth, R. AU - Klink, B. AU - Schrock, E. AU - Schackert, G. PY - 2017 DA - 2017// TI - Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells JO - BMC Cancer VL - 17 UR - https://doi.org/10.1186/s12885-017-3932-y DO - 10.1186/s12885-017-3932-y ID - Conde2017 ER - TY - JOUR AU - Lebelt, A. AU - Rutkowski, R. AU - Och, W. AU - Jaczun, K. AU - Dziemianczyk-Pakiela, D. AU - Milewski, R. PY - 2016 DA - 2016// TI - Survivin, caspase-3 and MIB-1 expression in astrocytic tumors of various grades JO - Adv Med Sci VL - 61 UR - https://doi.org/10.1016/j.advms.2016.02.001 DO - 10.1016/j.advms.2016.02.001 ID - Lebelt2016 ER - TY - JOUR AU - Haberler, C. AU - Slavc, I. AU - Czech, T. AU - Gelpi, E. AU - Heinzl, H. AU - Budka, H. PY - 2006 DA - 2006// TI - Histopathological prognostic factors in medulloblastoma: high expression of survivin is related to unfavourable outcome JO - Eur J Cancer VL - 42 UR - https://doi.org/10.1016/j.ejca.2006.05.038 DO - 10.1016/j.ejca.2006.05.038 ID - Haberler2006 ER - TY - JOUR AU - Brun, S. N. AU - Markant, S. L. AU - Esparza, L. A. AU - Garcia, G. AU - Terry, D. AU - Huang, J. M. PY - 2015 DA - 2015// TI - Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma JO - Oncogene VL - 34 UR - https://doi.org/10.1038/onc.2014.304 DO - 10.1038/onc.2014.304 ID - Brun2015 ER - TY - JOUR AU - Morrison, D. J. AU - Hogan, L. E. AU - Condos, G. AU - Bhatla, T. AU - Germino, N. AU - Moskowitz, N. P. PY - 2012 DA - 2012// TI - Endogenous knockdown of survivin improves chemotherapeutic response in ALL models JO - Leukemia VL - 26 UR - https://doi.org/10.1038/leu.2011.199 DO - 10.1038/leu.2011.199 ID - Morrison2012 ER - TY - JOUR AU - Yamanaka, K. AU - Nakahara, T. AU - Yamauchi, T. AU - Kita, A. AU - Takeuchi, M. AU - Kiyonaga, F. PY - 2011 DA - 2011// TI - Antitumor activity of YM155, a selective small-molecule survivin suppressant, alone and in combination with docetaxel in human malignant melanoma models JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-3410 DO - 10.1158/1078-0432.CCR-10-3410 ID - Yamanaka2011 ER - TY - JOUR AU - Chakravarti, A. AU - Zhai, G. G. AU - Zhang, M. AU - Malhotra, R. AU - Latham, D. E. AU - Delaney, M. A. PY - 2004 DA - 2004// TI - Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms JO - Oncogene VL - 23 UR - https://doi.org/10.1038/sj.onc.1208049 DO - 10.1038/sj.onc.1208049 ID - Chakravarti2004 ER - TY - JOUR AU - Rodel, F. AU - Frey, B. AU - Leitmann, W. AU - Capalbo, G. AU - Weiss, C. AU - Rodel, C. PY - 2008 DA - 2008// TI - Survivin antisense oligonucleotides effectively radiosensitize colorectal cancer cells in both tissue culture and murine xenograft models JO - Int J Radiat Oncol Biol Phys VL - 71 UR - https://doi.org/10.1016/j.ijrobp.2008.02.011 DO - 10.1016/j.ijrobp.2008.02.011 ID - Rodel2008 ER - TY - JOUR AU - Yang, W. AU - Cooke, M. AU - Duckett, C. S. AU - Yang, X. AU - Dorsey, J. F. PY - 2014 DA - 2014// TI - Distinctive effects of the cellular inhibitor of apoptosis protein c-IAP2 through stabilization by XIAP in glioblastoma multiforme cells JO - Cell Cycle VL - 13 UR - https://doi.org/10.4161/cc.27880 DO - 10.4161/cc.27880 ID - Yang2014 ER - TY - JOUR AU - Li, F. AU - Aljahdali, I. AU - Ling, X. PY - 2019 DA - 2019// TI - Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study? JO - J Exp Clin Cancer Res VL - 38 UR - https://doi.org/10.1186/s13046-019-1362-1 DO - 10.1186/s13046-019-1362-1 ID - Li2019 ER - TY - JOUR AU - Caldas, H. AU - Jiang, Y. AU - Holloway, M. P. AU - Fangusaro, J. AU - Mahotka, C. AU - Conway, E. M. PY - 2005 DA - 2005// TI - Survivin splice variants regulate the balance between proliferation and cell death JO - Oncogene VL - 24 UR - https://doi.org/10.1038/sj.onc.1208350 DO - 10.1038/sj.onc.1208350 ID - Caldas2005 ER - TY - JOUR AU - Waligorska-Stachura, J. AU - Sawicka-Gutaj, N. AU - Zabel, M. AU - Andrusiewicz, M. AU - Gut, P. AU - Czarnywojtek, A. PY - 2017 DA - 2017// TI - Survivin DEx3 as a biomarker of thyroid cancers: a study at the mRNA and protein level JO - Oncol Lett VL - 13 UR - https://doi.org/10.3892/ol.2017.5713 DO - 10.3892/ol.2017.5713 ID - Waligorska-Stachura2017 ER -